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It is an honor and a challenge to become the tenth
Editor-in-Chief of The American Journal of Pathology, es-
pecially following in the footsteps of pre-eminent previous
editors such as James Madara, Nelson Fausto, and Vin-
cent Marchesi in the past 20 years and before that
Donald Hackel, Thomas Kinney, Carl Weller, and F.B.
Mallory. The mission of the journal remains the same in
this new century: to publish high-quality original papers
on the cellular and molecular mechanisms of disease that
report important findings on disease pathogenesis or
basic biological mechanisms relating to disease. Times
have changed, however. The “science” of pathology has
progressed in the past century from descriptive tissue-
based observations, through analysis of molecules in
models of disease states to the future focused on molec-
ular pathogenesis and molecular therapeutics for human
disease. Thus, there is an increasing focus on transla-
tional research that directly impacts human disease. The
American Journal of Pathology is ideally situated to cap-
ture the excitement of this evolving area of research. The
catchwords of modern biomedical research including the
“omics,” prote- and gen-, regenerative medicine, human
gene therapy, and “bench to bedside,” all fit the portfolio
of The American Journal of Pathology.
Gene P. Siegal, M.D., Ph.D., an excellent experimental
pathologist, has assumed the Senior Associate Editor-
ship. The new roster of outstanding Associate Editors is a
combination of experienced scientists who have agreed
to continue serving: Drs. Lora Hedrick Ellenson, Patricia
D’Amore, Philip Furmanski, Setsuo Hirohashi, Sem Phan,
and Charles Parkos, as well as new outstanding investi-
gators: Drs. Jeffrey Cossman, Mary Hendrix, David Hock-
enbery, Andrew Lackner, Kevin Moore, Kevin Roth, and
Jeffrey Saffitz. I want to sincerely thank outgoing Associ-
ate Editors Drs. Kenneth Bernstein, John Chan, Jonathan
Fletcher, Edward Koo, Steven Kunkel, Massimo Pig-
natelli, and William Stetler-Stevenson, and Senior Asso-
ciate Editor Godfrey Getz, all of whom have so capably
served this past term.
Changes are inevitable and we hope to make those
that enhance the value of The American Journal of Pathol-
ogy to its readers. This goal is heightened by the realiza-
tion that pathology is not a defined scientific discipline,
but rather a scientific focus bringing together a myriad of
scientific disciplines. In that regard, I am soliciting ideas
for changes that you think would improve the journal.
Currently (2001 JCR Science Edition), AJP has an impact
rating of 7.103. We are in excellent company with other
outstanding journals. For example, The Journal of Immu-
nology and The Journal of Biological Chemistry have rat-
ings of 7.065 and 7.258, respectively. Your ideas for
improvement will be considered very carefully.
Specific areas that are currently being addressed:
1. Fast turnaround online submissions: We anticipate a
turnaround time of 35 days from submission to decision.
2. Review articles: Beginning immediately, we will so-
licit topical reviews. We have developed a process and
guidelines as outlined in the “Instructions to Authors” and
encourage such submissions.
3. Subsections: We are considering subsections to
help both our authors and our readers.
4. Top 10 list: Monthly, we will publish a list of The Amer-
ican Journal of Pathology’s top 10most-read articles, to draw
attention to classical and critical breakthroughs in science
and medicine achieved through the journal.
5. Continuing medical education: We are exploring
whether a continuing medical education program
through The American Journal of Pathology is desirable
and, if so, what is the best format in which to deliver it to
readers.
6. Online activities: Journal clubs, grand rounds, and
other options are also being considered.
I am certain that my job will be made infinitely easier
due to the excellent editorial office under the leadership
of Priscilla Markwood and her extraordinary staff.
Finally, I would like to thank Dr. Nelson Fausto, one of
the truly great experimental pathologists and individuals.
His devoted work writing “This Month in AJP” and his
previous outstanding editorship of AJP have had a major
impact on the journal. His commitment to the highest
quality of academics is unsurpassed. And to Dr. Jim
Madara, who handed the torch to me, I admire your
performance as Editor-in-Chief and as one of the true
leaders in academia, and know you will continue to be
successful in your position as Dean of the Division of the
Biological Sciences and the Pritzker School of Medicine,
and Vice President for Medical Affairs at the University of
Chicago.
I look forward to your input as we move rapidly into
an era that highlights the molecular pathogenesis of
disease.
Jay M. McDonald, M.D.
Editor-in-Chief
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